Skip to content

Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries

Cesarean Scar Characteristics After Scheduled and Emergency Cesarean Deliveries: A Single Center Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03609281
Enrollment
900
Registered
2018-08-01
Start date
2018-08-01
Completion date
2019-03-31
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Scar Niche, Cesarean Section; Dehiscence, Cesarean Wound; Dehiscence

Brief summary

This study was designed to evaluate the scar characteristics following scheduled and emergency cesarean deliveries.

Detailed description

design and settings: This study is a descriptive, cross-sectional and multicenter study conducted at Tanta and Benha Universities, Egypt in the period from August, 1, 2018 to December, 31, 2018. Patients: Eligibility: Nine hundred patients were selected carefully according to inclusion and exclusion criteria. The inclusion criteria were: (i) Primipara having prior cesarean delivery whether scheduled or emergency (ii) Term delivery ≥ 37 weeks of gestation (iii) Multipara having the last delivery by cesarean either scheduled or emergency (iv) The interval following cesarean delivery to be 6 months at least and (v) Double-layer repair of uterus and (vi) Cesarean by pfannensteil incisions. The exclusion criteria were: (i) Repeat cesarean sections (ii) Preterm delivery (iii) Associated placental abnormalities (iv) Single-layer repair of uterus and (v) Refusal to participate. Allocations: This study is not a clinical trial so allocation is made based on characteristics of patients and eligibility to be allocated in either scheduled cesarean group or emergency cesarean group. The allocation was not equal based on the percentage of patients in either group. The scheduled cesarean group included 580 cases while the emergency cesarean group included 320 cases from both universities. Intervention: Cesarean scar assessment included both uterine scar and cutaneous scar. The uterine scar was assessed by transvaginal 3D ultrasound. The used device in both universities was DC-30 device of Mindray Company. All ultrasound examinations were conducted by third author in this study. Cutaneous scar was assessed by surgery department represented by the fourth author in this study. The uterine scar in both groups was examined for distance from internal os, length, thickness, volume, vasculature and presence of any defects. Cutaneous scar was examined for distance from symphysis pubis, length, shape, any depressed areas, any defects (hernia orifice), sinus and presence of keloid or hypertrophic scar.

Interventions

RADIATIONUltrasound assessement of uterine scar

3D ultrasound assessment of scar characteristics

Sponsors

Tanta University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Primipara delivered by cs * Multipara with last delivery by cs * Full term delivery \>37 weeks * Double layer cesarean repair * Pfannenstiel incison

Exclusion criteria

* Repeat cs * Any placental abnormalities * Preterm delivery * Single layer cesarean repair * Refusal to participate

Design outcomes

Primary

MeasureTime frameDescription
Scar characteristics6 monthsSite of scar in relation to internal os of cervix
Scar length6 monthslength of scar in mm
thickness of scar6 monthsScar depth in mm
Scar volume6 monthsLength multiplied by width multiplied by depth
Scar vascularity6 monthDoppler on scar to assess vascularity

Secondary

MeasureTime frameDescription
Scar defect or niche6 monthsAssessment of scar weakness or scar defect by ultrasound with measurement of depth, width and length of defects plus the residual myometrial tissue

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026